Purpose

This report seeks approval of a
variation to the contract for Camden’s Adult Substance Misuse
Treatment and Recovery Service. The contract was awarded in
November 2022 to Change Grow Live Services Ltd and began on
1st April 2023. The clauses within the contract permit
for variations in Years 1-3 to reflect Supplementary Substance
Misuse Treatment and Recovery Grant allocations. This clause was
added following discussions with legal and procurement colleagues
to ensure the contract was sufficiently flexible and new investment
could be mobilised quickly.
 
In October 2023, Camden were
notified, by the Office of Health Improvement and Disparities, that
their Supplementary Substance Misuse Treatment and Recovery Grant
(SSMTR) allocation for 2024/25 (Year 3) would be
£2,792,326.  Since then, officers have been
liaising with key delivery partners and grant leads at the Office
of Health Improvement and Disparities to agree how the grant can be
spent to support Camden in achieving the outcomes outlined in the
national Drug Strategy.
 
This report seeks to allocate a
further £50,000 to Change Grow Live (CGL) to deliver
interventions to support the local delivery of the national drug
strategy.
 
This report is being presented to Director of
Health and Wellbeing for approval in line with
Contract Standing Order E1. 
 
 

Content

THAT the Director of Health and Wellbeing approves
the variation of the contract with Change Grow Live Services Ltd to
reflect a further increase in the contract price for 2024/25 of
£50,000 to reflect re-profiled funding available from the
Supplementary Substance Misuse Treatment and Recovery Grant
allocation.